Ampio announces voluntary delisting and sec deregistration

Englewood, colo. , march 25, 2024 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american: ampe) (the "company" or "ampio") today announced that its board of directors determined to voluntarily delist its common stock from the nyse american and deregister its common stock in order to terminate and suspend its reporting obligations under the securities and exchange act of 1934, as amended (the "exchange act").
AMPE Ratings Summary
AMPE Quant Ranking